Submitted:
20 December 2023
Posted:
20 December 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Animals, design and diets
| Items | Proportion/% |
| Corn | 45.00 |
| Wheat bran | 35.00 |
| Soybean mea | 16.00 |
| Additive premixes 2624 | 4.00 |
| DE (Mcal/kg) | 2.8487 |
| CP (%) | 15.89 |
| CF(%) | 3.94 |
| Ca (%) | 0.70 |
| TP (%) | 0.66 |
| NPP (%) | 0.30 |
| Lys (%) | 0.79 |
| Met+Cys(%) | 0.53 |
| Thr (%) | 0.58 |
| Trp (%) | 0.21 |
| Groups | Initial weight (kg) | Diarrhoea rate in piglets (%) | Average daily weight gain (ADG, kg) | Average daily feed intake (ADFI, kg) | feed-to-weight ratio (F/G) | finaly weight (kg) |
| Nor | 5.42±0.06 | 10.5%±0.01A | 0.037±0.00C | 0.414±0.25 | 11.19±0.11A | 6.97±0.47A |
| Ant | 5.43±0.07 | 7.8%±0.00B | 0.083±0.00A | 0.451±0.00 | 5.43±0.36B | 8.93±0.09B |
| Tib | 5.40±0.03 | 8.2%±0.00B | 0.089±0.00A | 0.449±0.03 | 5.04±0.04B | 9.13±0.35B |
| Fec | 5.48±0.09 | 8.2%±0.00B | 0.06±0.00B | 0.413±0.02 | 6.88±0.18C | 8.00±0.10C |
2.2. Growth Performance
2.3. Sample collection and processing
2.4. LC-MS analysis
2.5. Mass spectrometer parameters
2.6. Preprocessing and quality control of raw sequencing data
2.7. Statistical analysis
3. Results
3.1. Growth performance
3.2. Comparison of blood physiological indicators
| Norm | Unit | Nor1 | Ant1 | Tib1 | Fec1 |
| WBC | 109/L | 19.67±0.43a | 28.03±0.57b | 27.83±0.22b | 29.23±0.93b |
| RBC | 1012/L | 7.96±0.20a | 8.66±0.18b | 8.12±0.31b | 8.65±0.20b |
| HGB | g/L | 133.00±0.58a | 148.67±1.45b | 147.33±8.09b | 145.33±0.88b |
| HCT | % | 42.90±0.46 | 44.80±1.16 | 42.90±1.30 | 44.67±0.20 |
| MCV | fL | 54.73±0.73 | 54.77±0.24 | 55.43±0.07 | 53.77±0.20 |
| MCH | Pg | 17.56±0.30 | 17.57±0.07 | 17.77±0.09 | 17.40±0.06 |
| MCHC | g/L | 322.08±1.92 | 322.67±1.76 | 322.00±2.52 | 321.67±1.73 |
| RDW | % | 16.23±0.46 | 16.83±1.30 | 16.10±0.10 | 17.30±0.50 |
| MPV | fL | 7.93±0.27 | 7.40±0.35 | 7.70±0.06 | 7.47±0.23 |
| PDW | % | 16.63±0.15 | 16.63±0.13 | 16.50±0.15 | 16.50±0.10 |
| PCT | % | 0.32±0.04 | 0.25±0.01 | 0.30±0.01 | 0.30±0.05 |
3.3. Quality control
3.4. Multivariate statistical analysis
| Group | R2X(cum) | R2Y(cum) | Q2(cum) |
| Nor1vsAnt1 | 0.669 | 0.994 | 0.955 |
| Nor1vsTib1 | 0.722 | 0.995 | 0.964 |
| Nor1vsFec1 | 0.482 | 0.983 | 0.871 |
| Ant1vsTib1 | 0.601 | 0.978 | 0.767 |
| Ant1vsFec1 | 0.597 | 0.998 | 0.955 |
| Tib1vsFec1 | 0.587 | 0.996 | 0.910 |
| Nor2vsAnt2 | 0.572 | 0.967 | 0.569 |
| Nor2vsTib2 | 0.578 | 0.976 | 0.518 |
| Nor2vsFec2 | 0.533 | 0.981 | 0.549 |
| Ant2vsTib2 | 0.668 | 0.979 | 0.700 |
| Ant2vsFec2 | 0.721 | 0.990 | 0.799 |
| Tib2vsFec2 | 0.714 | 0.902 | 0.744 |
3.5. Screening for differential metabolites
| Metabolites | VIP | P value | FC | Trend |
| Stearamide | 2.22 | 0.009 | 7.76 | up |
| Choline | 3.11 | 0.001 | 7.18 | up |
| 1-Stearoylglycerol | 1.12 | 0.005 | 6.94 | up |
| trans-Petroselinic Acid | 3.19 | 0.008 | 5.51 | up |
| L-(-)-Malic acid | 1.76 | 0.007 | 3.89 | up |
| 4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside | 5.89 | 0.002 | 2.44 | up |
| 4-Hydroxybenzoic acid | 5.36 | 0.001 | 2.24 | up |
| Dihydrozeatin | 3.52 | 0.002 | 1.90 | up |
| Panaxtriol | 1.34 | 0.009 | 1.60 | up |
| Stearic Acid | 1.72 | 0.004 | 1.36 | up |
| 2,8-Quinolinediol | 1.89 | 0.008 | 15.31 | down |
| trans-3-Hexenoic acid | 1.40 | 0.009 | 10.96 | down |
| Methionine | 1.61 | 0.004 | 10.36 | down |
| Lithocholic Acid | 1.54 | 0.000 | 8.28 | down |
| 3-Hydroxy-3-methylbutanoic acid | 4.68 | 0.000 | 6.86 | down |
| N-Acetyl-D-alloisoleucine | 3.95 | 0.003 | 4.10 | down |
| N-Acetyl-L-leucine | 3.75 | 0.000 | 3.50 | down |
| 4-Hydroxybutyric acid (GHB) | 2.33 | 0.007 | 3.35 | down |
| Isoquinoline | 2.30 | 0.008 | 2.90 | down |
| Indole-3-acetic acid | 2.75 | 0.008 | 2.78 | down |
| Metabolites | VIP | P value | FC | Trend |
| Bullatine A | 8.14 | 0.000 | 1.39 | up |
| Prostaglandin E2-1-glyceryl ester | 6.19 | 0.009 | 6.80 | up |
| 4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside | 5.68 | 0.005 | 2.30 | up |
| (+)12(13)-DiHOME | 3.51 | 0.007 | 4.29 | up |
| 19(R)-hydroxy Prostaglandin A2 | 2.83 | 0.000 | 1.14 | up |
| PC (20:3e/22:5) | 2.82 | 0.000 | 1.11 | up |
| Choline | 2.68 | 0.006 | 6.13 | up |
| 3-Methylglutaric acid | 2.43 | 0.000 | 1.95 | up |
| N1-(2-piperidinophenyl)-3,4,5-trimethoxybenzamide | 2.24 | 0.001 | 1.09 | up |
| 2-Oxindole | 1.83 | 0.009 | 5.53 | up |
| 4-Hydroxybenzaldehyde | 1.22 | 0.004 | 4.38 | down |
| L-Phenylalanine | 1.24 | 0.008 | 12.15 | down |
| Methionine | 1.31 | 0.002 | 10.13 | down |
| Norleucine | 1.82 | 0.003 | 1.04 | down |
| DL-Tryptophan | 1.86 | 0.007 | 8.47 | down |
| Indole-3-acrylic acid | 1.87 | 0.007 | 8.61 | down |
| N1-[4-hydroxy-6-(methoxymethyl)pyrimidin-2-yl]acetamide | 1.88 | 0.003 | 2.09 | down |
| N-Isobutyrylglycine | 2.01 | 0.002 | 1.46 | down |
| 5-amino-1-phenyl-1H-pyrazole-4-carbohydrazide | 2.06 | 0.009 | 1.80 | down |
| (2-oxo-2,3-dihydro-1H-indol-3-yl)acetic acid | 2.11 | 0.000 | 1.39 | down |
| Metabolites | VIP | P value | FC | Trend |
| FAHFA (22:4/3:0) | 2.94 | 0.005 | 4.34 | up |
| gamma-Glutamylleucine | 1.14 | 0.001 | 2.82 | up |
| N-Acetylhistamine | 1.53 | 0.001 | 2.70 | up |
| 2-Methylnicotinamide | 1.55 | 0.001 | 2.70 | up |
| (+/-)12(13)-DiHOME | 1.51 | 0.005 | 2.64 | up |
| Lactitol | 4.87 | 0.000 | 1.28 | up |
| MGDG (19:2/18:4) | 1.25 | 0.003 | 1.17 | up |
| L-Argininosuccinate | 1.86 | 0.000 | 1.16 | up |
| 3-Hydroxyanthranilic acid | 2.89 | 0.007 | 1.08 | up |
| 2,8-Quinolinediol | 5.42 | 0.000 | 26.55 | down |
| L-Tyrosine | 2.03 | 0.005 | 14.97 | down |
| N-Benzylformamide | 2.12 | 0.002 | 11.26 | down |
| 4-Hydroxybenzaldehyde | 2.52 | 0.000 | 7.87 | down |
| 5-Hydroxyindole-3-acetic acid | 2.30 | 0.009 | 5.10 | down |
| 5-Hydroxyindole | 4.39 | 0.001 | 4.39 | down |
| Dopamine | 3.50 | 0.000 | 2.55 | down |
| (2-oxo-2,3-dihydro-1H-indol-3-yl)acetic acid | 2.08 | 0.000 | 1.99 | down |
| N1-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamide | 2.40 | 0.003 | 1.94 | down |
| Glucuronic acid-3,6-lactone | 2.20 | 0.003 | 1.85 | down |
| Metabolites | VIP | P value | FC | Trend |
| ERH | 5.95 | 0.001 | 1.28 | up |
| 3,3-Dimethylglutaric acid | 1.11 | 0.000 | 1.72 | up |
| Phenethyl isothiocyanate | 0.71 | 0.005 | 1.08 | down |
| Ethylmalonic acid | 1.03 | 0.009 | 2.23 | down |
| D-(-)-Lyxose | 1.19 | 0.001 | 1.70 | down |
| N6-Acetyl-L-lysine | 1.78 | 0.000 | 5.17 | down |
| (+/-)12(13)-DiHOME | 2.00 | 0.008 | 13.11 | down |
| 11-Epiprostaglandin E1 | 2.04 | 0.001 | 5.08 | down |
| Dehydrodiisoeugenol | 2.89 | 0.004 | 1.03 | down |
| Metabolites | VIP | P value | FC | Trend |
| Bullatine A | 8.00 | 0.000 | 2.72 | up |
| Piperine | 5.44 | 0.001 | 1.07 | up |
| D-Ribulose 1,5-bisphosphate | 2.91 | 0.006 | 2.23 | up |
| 3-(3-bromo-4-hydroxy-5-methoxyphenyl)-2-cyanoacrylamide | 2.78 | 0.007 | 3.70 | up |
| Cyanidin | 1.51 | 0.005 | 1.08 | up |
| Metabolites | VIP | P value | FC | Trend |
| N-(3-chloro-2-methylphenyl)-N’-(3-methoxypropyl)thiourea | 6.17 | 0.000 | 1.17 | up |
| Lactitol | 5.32 | 0.002 | 1.88 | up |
| 3-Iodo-L-tyrosine | 4.47 | 0.042 | 2.14 | up |
| L-Threonic acid-1,4-lactone | 3.36 | 0.048 | 3.79 | up |
| D-Ribulose 1,5-bisphosphate | 3.28 | 0.005 | 1.90 | up |
| (+/-)-CP 47,497-C7-Hydroxy metabolite | 3.23 | 0.044 | 2.77 | up |
| 3-(3-bromo-4-hydroxy-5-methoxyphenyl)-2-cyanoacrylamide | 2.74 | 0.030 | 2.51 | up |
| Cyanidin | 2.08 | 0.001 | 1.09 | up |
| Acetophenone | 1.15 | 0.034 | 23.03 | up |
| FAHFA (8:0/18:3) | 1.14 | 0.043 | 1.41 | up |
| 5(S),15(S)-DiHETE | 1.23 | 0.039 | 1.59 | down |
| 3-(propan-2-yl)-octahydropyrrolo [1,2-a]pyrazine-1,4-dione | 1.41 | 0.004 | 1.18 | down |
| Ribitol | 1.57 | 0.000 | 1.05 | down |
| Uric acid | 3.70 | 0.047 | 5.29 | down |
3.6. KEGG analysis of differential metabolites

3.7. Metabolite KEGG enrichment circle plot analysis

4. Discussion
5. Conclusions
Funding
Acknowledgment
Conflict of Interest
References
- Campbell JM, Crenshaw JD, Polo J. The biological stress of early weaned piglets[J]. J Anim Sci Biotechnol, 2013, 4(1):19. [CrossRef]
- Spring S, Premathilake H, Bradway C et al. Effect of very low-protein diets supplemented with branched-chain amino acids on energy balance, plasma metabolomics and fecal microbiome of pigs[J]. Sci Rep, 2020, 10(1):15859. [CrossRef]
- Canibe N, Hojberg O, Kongsted H et al. Review on Preventive Measures to Reduce Post-Weaning Diarrhoea in Piglets[J]. Animals (Basel), 2022, 12(19):2585. [CrossRef]
- Lin C, Wan J, Su Y et al. Effects of Early Intervention with Maternal Fecal Microbiota and Antibiotics on the Gut Microbiota and Metabolite Profiles of Piglets[J]. Metabolites, 2018, 8(4):89. [CrossRef]
- Youngster I, Sauk J, Pindar C et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study[J]. Clin Infect Dis, 2014, 58(11):1515-1522. [CrossRef]
- Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications[J]. Nat Rev Gastroenterol Hepatol, 2011, 9(2):88-96. [CrossRef]
- Heath RD, Cockerell C, Mankoo R et al. Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders[J]. North Clin Istanb, 2018, 5(1):79-88. [CrossRef]
- Pigneur B, Sokol H. Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail[J]. Mucosal Immunol, 2016, 9(6):1360-1365. [CrossRef]
- Cheng S, Ma X, Geng S et al. Fecal Microbiota Transplantation Beneficially Regulates Intestinal Mucosal Autophagy and Alleviates Gut Barrier Injury[J]. mSystems, 2018, 3(5):e00137-00118. [CrossRef]
- Hu J, Ma L, Nie Y et al. A Microbiota-Derived Bacteriocin Targets the Host to Confer Diarrhea Resistance in Early-Weaned Piglets[J]. Cell Host Microbe, 2018, 24(6):817-832 e818. [CrossRef]
- Xiang Q, Wu X, Pan Y et al. Early-Life Intervention Using Fecal Microbiota Combined with Probiotics Promotes Gut Microbiota Maturation, Regulates Immune System Development, and Alleviates Weaning Stress in Piglets[J]. Int J Mol Sci, 2020, 21(2):503. [CrossRef]
- Wang H, Xu R, Zhang H et al. Swine gut microbiota and its interaction with host nutrient metabolism[J]. Anim Nutr, 2020, 6(4):410-420. [CrossRef]
- Kurbatov I, Dolgalev G, Arzumanian V et al. The Knowns and Unknowns in Protein-Metabolite Interactions[J]. Int J Mol Sci, 2023, 24(4):4155. [CrossRef]
- Zhu LR, Li SS, Zheng WQ et al. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy[J]. Front Immunol, 2023, 14:1086078. [CrossRef]
- Gresse R, Chaucheyras-Durand F, Fleury MA et al. Gut Microbiota Dysbiosis in Postweaning Piglets: Understanding the Keys to Health[J]. Trends Microbiol, 2017, 25(10):851-873. [CrossRef]
- Wang T, Teng K, Liu Y et al. Lactobacillus plantarum PFM 105 Promotes Intestinal Development Through Modulation of Gut Microbiota in Weaning Piglets[J]. Front Microbiol, 2019, 10:90. [CrossRef]
- Hu J, Chen L, Tang Y et al. Standardized Preparation for Fecal Microbiota Transplantation in Pigs[J]. Front Microbiol, 2018, 9:1328. [CrossRef]
- Nowland TL, Torok VA, Low WY et al. A single faecal microbiota transplantation altered the microbiota of weaned pigs[J]. Life, 2020, 10(9):203. [CrossRef]
- Liu T, Guo Y, Lu C et al. Effect of Different Pig Fecal Microbiota Transplantation on Mice Intestinal Function and Microbiota Changes During Cold Exposure[J]. Front Vet Sci, 2022, 9:805815. [CrossRef]
- Diao H, Yan HL, Xiao Y et al. Intestinal microbiota could transfer host Gut characteristics from pigs to mice[J]. BMC microbiology, 2016, 16(1):238. [CrossRef]
- Zierer J, Jackson MA, Kastenmuller G et al. The fecal metabolome as a functional readout of the gut microbiome[J]. Nat Genet, 2018, 50(6):790-795. [CrossRef]
- Jayaraman B, Nyachoti CM. Husbandry practices and gut health outcomes in weaned piglets: A review[J]. Anim Nutr, 2017, 3(3):205-211. [CrossRef]
- Li M, Li F, Lu Z et al. Effects of TiO(2) nanoparticles on intestinal microbial composition of silkworm, Bombyx mori[J]. Sci Total Environ, 2020, 704:135273. [CrossRef]
- Barnes D, Ng K, Smits S et al. Competitively Selected Donor Fecal Microbiota Transplantation: Butyrate Concentration and Diversity as Measures of Donor Quality[J]. J Pediatr Gastroenterol Nutr, 2018, 67(2):185-187. [CrossRef]
- Rahman R, Fouhse JM, Prisnee TL et al. Comparing the impact of mixed-culture microbial communities and fecal transplant on the intestinal microbiota and metabolome of weaned piglets[J]. FEMS Microbiol Ecol, 2023, 99(7). [CrossRef]
- Qi R, Zhang Z, Wang J et al. Introduction of Colonic and Fecal Microbiota From an Adult Pig Differently Affects the Growth, Gut Health, Intestinal Microbiota and Blood Metabolome of Newborn Piglets[J]. Front Microbiol, 2021, 12:623673. [CrossRef]
- Hu L, Geng S, Li Y et al. Exogenous Fecal Microbiota Transplantation from Local Adult Pigs to Crossbred Newborn Piglets[J]. Front Microbiol, 2017, 8:2663. [CrossRef]
- Mathew DJ, Lucy MC, R DG. Interleukins, interferons, and establishment of pregnancy in pigs[J]. Reproduction, 2016, 151(6):R111-122. [CrossRef]
- Quinn JG, Tansey EA, Johnson CD et al. Blood: tests used to assess the physiological and immunological properties of blood[J]. Adv Physiol Educ, 2016, 40(2):165-175. [CrossRef]
- Moraes LA, Piqueras L, Bishop-Bailey D. Peroxisome proliferator-activated receptors and inflammation[J]. Pharmacol Ther, 2006, 110(3):371-385. [CrossRef]
- Yang R, Gao G, Liu T et al. Enhanced ability of hemoglobin to carry oxygen by salidroside[J]. Electrochemistry Communications, 2007, 9(1):94-96. [CrossRef]
- Gabler NK, Spurlock ME. Integrating the immune system with the regulation of growth and efficiency[J]. J Anim Sci, 2008, 86(14 Suppl):E64-74. [CrossRef]
- Smuda K, Gienger J, Hönicke P et al. Function of hemoglobin-based oxygen carriers: Determination of methemoglobin content by spectral extinction measurements[J]. International Journal of Molecular Sciences, 2021, 22(4):1753. [CrossRef]
- Hu TY, Ju JM, Mo LH et al. Anti-inflammation action of xanthones from Swertia chirayita by regulating COX-2/NF-kappaB/MAPKs/Akt signaling pathways in RAW 264.7 macrophage cells[J]. Phytomedicine, 2019, 55:214-221. [CrossRef]
- Liu CS, Liang X, Wei XH et al. Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids[J]. Front Microbiol, 2019, 10:825. [CrossRef]
- Zhao J, Zhang G, Zhou X et al. Effect of Dandelion root extract on growth performance, immune function and bacterial community in weaned pigs[J]. Food and Agricultural Immunology, 2019, 30(1):95-111. [CrossRef]
- Wang M, Huang H, Hu Y et al. Effects of dietary supplementation with herbal extract mixture on growth performance, organ weight and intestinal morphology in weaning piglets[J]. J Anim Physiol Anim Nutr (Berl), 2020, 104(5):1462-1470. [CrossRef]
- Xia Z, Zhang Y, Li C et al. Traditional Tibetan medicine Anzhijinhua San attenuates ovalbumin-induced diarrhea by regulating the serotonin signaling system in mice[J]. J Ethnopharmacol, 2019, 236:484-494. [CrossRef]
- Chen G, Li Z, Liu S et al. Fermented chinese herbal medicine promoted growth performance, intestinal health, and regulated bacterial microbiota of weaned piglets[J]. Animals, 2023, 13(3):476. [CrossRef]
- Świtała M, Kołacz R, Bodak-Koszałka E et al. Haematological and biochemical parameters of blood and immune response of runt weaners[J]. Journal of Animal and Feed Sciences, 1998, 7:405-413. [CrossRef]
- Xu Q, Cheng M, Jiang R et al. Effects of dietary supplement with a Chinese herbal mixture on growth performance, antioxidant capacity, and gut microbiota in weaned pigs[J]. Front Vet Sci, 2022, 9:971647. [CrossRef]
- Mahmud MR, Jian C, Uddin MK et al. Impact of Intestinal Microbiota on Growth Performance of Suckling and Weaned Piglets[J]. Microbiol Spectr, 2023, 11(3):e0374422. [CrossRef]
- Lee K, Kwak JH, Pyo S. Inhibition of LPS-induced inflammatory mediators by 3-hydroxyanthranilic acid in macrophages through suppression of PI3K/NF-κB signaling pathways[J]. Food Funct, 2016, 7(7):3073-3082. [CrossRef]
- Yoon SJ, Kim SJ, Lee SM. Overexpression of HO-1 Contributes to Sepsis-Induced Immunosuppression by Modulating the Th1/Th2 Balance and Regulatory T-Cell Function[J]. J Infect Dis, 2017, 215(10):1608-1618. [CrossRef]
- Yan Y, Zhang GX, Gran B et al. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis[J]. J Immunol, 2010, 185(10):5953-5961. [CrossRef]
- Xia TT, Hu R, Shao CJ et al. Stanniocalcin-1 secreted by human umbilical mesenchymal stem cells regulates interleukin-10 expression via the PI3K/AKT/mTOR pathway in alveolar macrophages[J]. Cytokine, 2023, 162:156114. [CrossRef]
- Grifka-Walk HM, Jenkins BR, Kominsky DJ. Amino Acid Trp: The Far Out Impacts of Host and Commensal Tryptophan Metabolism[J]. Front Immunol, 2021, 12:653208. [CrossRef]
- Lu Y, Chong J, Shen S et al. TrpNet: Understanding Tryptophan Metabolism across Gut Microbiome[J]. Metabolites, 2021, 12(1). [CrossRef]
- Hyland NP, Cavanaugh CR, Hornby PJ. Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function[J]. Amino Acids, 2022, 54(1):57-70. [CrossRef]
- Konopelski P, Ufnal M. Indoles - Gut Bacteria Metabolites of Tryptophan with Pharmacotherapeutic Potential[J]. Curr Drug Metab, 2018, 19(10):883-890. [CrossRef]
- Wang YD, Chen WD, Yu D et al. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice[J]. Hepatology, 2011, 54(4):1421-1432.
- Keitel V, Donner M, Winandy S et al. Expression and function of the bile acid receptor TGR5 in Kupffer cells[J]. Biochem Biophys Res Commun, 2008, 372(1):78-84. [CrossRef]
- Potthoff MJ, Boney-Montoya J, Choi M et al. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway[J]. Cell Metab, 2011, 13(6):729-738. [CrossRef]
- Liang H, Dai Z, Liu N et al. Dietary L-Tryptophan Modulates the Structural and Functional Composition of the Intestinal Microbiome in Weaned Piglets[J]. Front Microbiol, 2018, 9:1736. [CrossRef]
- Liu JR, Miao H, Deng DQ et al. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation[J]. Cell Mol Life Sci, 2021, 78(3):909-922. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).